NO171639C - Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater - Google Patents
Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivaterInfo
- Publication number
- NO171639C NO171639C NO893039A NO893039A NO171639C NO 171639 C NO171639 C NO 171639C NO 893039 A NO893039 A NO 893039A NO 893039 A NO893039 A NO 893039A NO 171639 C NO171639 C NO 171639C
- Authority
- NO
- Norway
- Prior art keywords
- imidazolpyrazold
- derivatives
- preparation
- therapeutic active
- aralkyl
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 2
- 125000005018 aryl alkenyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 abstract 1
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 230000000767 anti-ulcer Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
- F16B17/00—Connecting constructional elements or machine parts by a part of or on one member entering a hole in the other and involving plastic deformation
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18613288 | 1988-07-26 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO893039D0 NO893039D0 (no) | 1989-07-26 |
| NO893039L NO893039L (no) | 1990-01-29 |
| NO171639B NO171639B (no) | 1993-01-04 |
| NO171639C true NO171639C (no) | 1993-04-14 |
Family
ID=16182931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO893039A NO171639C (no) | 1988-07-26 | 1989-07-26 | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0353047B1 (no) |
| JP (1) | JPH0753730B2 (no) |
| KR (1) | KR940009785B1 (no) |
| CN (2) | CN1032207C (no) |
| AT (1) | ATE112569T1 (no) |
| CA (1) | CA1340444C (no) |
| DE (1) | DE68918651T2 (no) |
| DK (1) | DK369289A (no) |
| ES (1) | ES2065992T3 (no) |
| FI (1) | FI91871C (no) |
| HK (1) | HK1005732A1 (no) |
| IE (1) | IE68940B1 (no) |
| NO (1) | NO171639C (no) |
| ZA (1) | ZA895670B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5356897A (en) * | 1991-09-09 | 1994-10-18 | Fujisawa Pharmaceutical Co., Ltd. | 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines |
| DE10019714A1 (de) * | 2000-04-20 | 2002-01-10 | Gruenenthal Gmbh | Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen |
| US8377945B2 (en) * | 2009-06-15 | 2013-02-19 | Rigel Pharmaceuticals Inc. | Small molecule inhibitors of spleen tyrosine kinase (SYK) |
| CN101671336B (zh) * | 2009-09-23 | 2013-11-13 | 辽宁利锋科技开发有限公司 | 芳杂环并嘧啶衍生物和类似物及其制备方法和用途 |
| ES2639338T3 (es) * | 2012-01-25 | 2017-10-26 | Bayer Pharma Aktiengesellschaft | Fenilimidazopirazoles sustituidos y su uso |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2116971B (en) * | 1982-03-16 | 1985-03-27 | Erba Farmitalia | Substituted 1h-pyrazolo (1 5-a) pyrimidines and process for their preparation |
| JPH0231374B2 (ja) * | 1983-08-08 | 1990-07-12 | Fuji Photo Film Co Ltd | Harogenkaginkaraakankozairyo |
| GB8426447D0 (en) * | 1984-10-19 | 1984-11-28 | Kodak Ltd | Photographic colour couplers |
| JPS6296940A (ja) * | 1985-10-24 | 1987-05-06 | Fuji Photo Film Co Ltd | 熱現像感光材料 |
-
1989
- 1989-07-25 JP JP1191991A patent/JPH0753730B2/ja not_active Expired - Lifetime
- 1989-07-26 IE IE242889A patent/IE68940B1/en not_active IP Right Cessation
- 1989-07-26 NO NO893039A patent/NO171639C/no unknown
- 1989-07-26 CN CN89107035A patent/CN1032207C/zh not_active Expired - Fee Related
- 1989-07-26 DE DE68918651T patent/DE68918651T2/de not_active Expired - Fee Related
- 1989-07-26 DK DK369289A patent/DK369289A/da not_active Application Discontinuation
- 1989-07-26 CA CA000606704A patent/CA1340444C/en not_active Expired - Fee Related
- 1989-07-26 AT AT89307596T patent/ATE112569T1/de not_active IP Right Cessation
- 1989-07-26 ZA ZA895670A patent/ZA895670B/xx unknown
- 1989-07-26 KR KR1019890010576A patent/KR940009785B1/ko not_active IP Right Cessation
- 1989-07-26 EP EP89307596A patent/EP0353047B1/en not_active Expired - Lifetime
- 1989-07-26 ES ES89307596T patent/ES2065992T3/es not_active Expired - Lifetime
- 1989-07-26 FI FI893570A patent/FI91871C/fi not_active IP Right Cessation
-
1993
- 1993-12-10 CN CN93120938A patent/CN1034333C/zh not_active Expired - Fee Related
-
1998
- 1998-06-03 HK HK98104833A patent/HK1005732A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI893570A0 (fi) | 1989-07-26 |
| NO171639B (no) | 1993-01-04 |
| CA1340444C (en) | 1999-03-16 |
| JPH02124889A (ja) | 1990-05-14 |
| EP0353047B1 (en) | 1994-10-05 |
| CN1032207C (zh) | 1996-07-03 |
| CN1040196A (zh) | 1990-03-07 |
| FI893570A (fi) | 1990-01-27 |
| DE68918651T2 (de) | 1995-05-24 |
| HK1005732A1 (en) | 1999-01-22 |
| EP0353047A2 (en) | 1990-01-31 |
| CN1034333C (zh) | 1997-03-26 |
| KR900001701A (ko) | 1990-02-27 |
| ATE112569T1 (de) | 1994-10-15 |
| CN1094049A (zh) | 1994-10-26 |
| FI91871C (fi) | 1994-08-25 |
| JPH0753730B2 (ja) | 1995-06-07 |
| FI91871B (fi) | 1994-05-13 |
| DK369289D0 (da) | 1989-07-26 |
| NO893039D0 (no) | 1989-07-26 |
| DE68918651D1 (de) | 1994-11-10 |
| EP0353047A3 (en) | 1991-07-24 |
| DK369289A (da) | 1990-01-27 |
| ES2065992T3 (es) | 1995-03-01 |
| IE892428L (en) | 1990-01-26 |
| IE68940B1 (en) | 1996-07-24 |
| NO893039L (no) | 1990-01-29 |
| ZA895670B (en) | 1991-03-27 |
| KR940009785B1 (ko) | 1994-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO173014C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater | |
| NO882608D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyrideirer. | |
| NO904134D0 (no) | Fremgangsmaate for fremstilling av pyrazolderivater. | |
| NO171785C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinazolinderivater | |
| DK0736018T3 (da) | 4,5-Diaryloxazolderivater | |
| DK0770079T3 (da) | Heterobicykliske derivater | |
| NO166126C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
| NO172490C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater | |
| NO171639C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater | |
| ATE140229T1 (de) | Benzoxazepinon-verfahren | |
| NO894325L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater. | |
| NO165593C (no) | Analogifremgangsmaate ved fremstilling av nye tetracykliske indolderivater. |